| Company Name |
Mitsubishi Chemical Medience Corporation |
| Head office |
4-2-8, Shibaura, Minato-ku, Tokyo |
| President and CEO |
Shinichi Yoshihara |
| Paid-in capital |
3 billion yen |
| Net sales (whole group) |
78.3 billion yen (as of March 31, 2011) |
| Primary Business Domains |
・Clinical testing (biochemical testing, hematological testing, immunological testing,
microbiological testing, genetic testing, pathological and other testing) |
| ・Development, sale, export and import of in vitro diagnostic reagents and instruments |
| ・Preventive medical services |
| ・Medical services |
| ・Drug development support services (Nonclinical study, Clinical study) |
| ・In vitro cell assay (human cell) |
| ・Gene and protein analysis services |
| ・Environmental risk evaluation (pharmaceuticals, agrochemicals, industrial chemicals, food additives and cosmetics) |
| ・Food Safety Support services |
| ・Anti-Doping test |
Number of employees
(whole group) |
3,013 (as of March 31, 2011) |
| Executives and Operating Executives |
President and Chief Executive Officer |
Shinichi Yoshihara |
Senior Managing Executive Officer
Representative Director, Member of the Board |
Chiaki Roppongi |
Senior Managing Executive Officer
Representative Director, Member of the Board |
Kiyoshi Kurokawa |
| Executive Officer, Member of the Board |
Nobuyuki Kadoono |
| Executive Officer, Member of the Board |
Katsuki Itagaki |
| Executive Officer, Member of the Board |
Fuminori Nakamura |
| Executive Officer, Member of the Board |
Makoto Fujisaki |
| Member of the Board |
Shigeru Tsuyuki |
| Statutory Auditor |
Kiyotaka Hattori |
| Statutory Auditor |
Takamasa Nakae |
| Statutory Auditor |
Kazuchika Yamaguchi |
| Executive Officer |
Yukio Baba |
| Executive Officer |
Akio Ito |